TREACE MEDICAL CONCEPTS, INC.
TMCITreace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 6, 2026
28dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How TMCI's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is TREACE MEDICAL CONCEPTS, INC.'s next FDA catalyst?→
TREACE MEDICAL CONCEPTS, INC.'s (TMCI) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TMCI biotech catalysts?→
Add TMCI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow TREACE MEDICAL CONCEPTS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.